Lymphomia
Lymphomia has traditionally been grouped as either Hodgkin's lymphoma or non-Hodgekins limphoma, after Thomas Hodgin, the doctor who discovered the disease in the 1830's.
|
|
Later, this classification has become too coarse and a further grouping has become necessary. WHO (the World Health Organization) published a new type of classification in 2001, based on the revised "European-American lymphoma classification". In this newer classification, the lymphomas are grouped according to the main cell type involved and the new groups are - the B-cell tumors, the T-cell tumors (including natural killer cell tumors) and the Hodgekins lymphomia.
The B-cell tumors
- The small lymphocytic lymphomia (lymphocytic leukemia)
- Thymic large B cell lymphoma
- B-cell prolymphocytic leukemia
- Waldenström macroglobulinemia
- Splenic marginal zone lymphoma
- Plasma cell lymphoma's
- Follicular lymphomia
- MALT lymphoma
- Nodal marginal zone B cell limphoma
- Diffuse large B cell limphoma
- Intravascular large B cell limphoma
- Primary effusion lynphoma
- Mantle cell lymphoma
- Burkitt leukemia
- lymphomatiod granulomatosies
The mature T-cell and Natural Killer cell tumors
- T-cell large granules lymphocytic leucemia
- T-cell prolymphocytic leucemia
- Adult T-cell lymphoma
- Extranodial T-cell lymphoma
- Hepatosplenic T-cell lymphoma
- Aggressive natural killer cell leukemia
- Anaplastic large cell lymphoma
- Sezary's syndrome
- Primary cutaneous CD30-positive T-cell disorder
- Angioimmunoblastic T-cell lymphoma
- Blastric natural killer cell lymphoma
- Enteropathy-type T-cell limphoma
- Peripheral T-cell lymphomia
Hodgin's lymphomia
- Nodular lymphocyte-predominant Hodgin lymphoma
- Original Hodgekin lymphomia
Non-Hodgkin's Lymphoma
This disease has had a dramatic improvement in treatment success rate over the last 10 years as more treatments have become available. A bit over 50% of patients diagnosed with Non-Hodgekin's lymphoma will today live 5 years or more without the limphoma recurring. There are many independent factors contributing when deciding what treatment to use for these different lymphomas, the most important factors being tissue classification and a diagnose of the stage of the lymphomia.